Ingersoll Rand vs Xylem
IR and XYL side by side, both in general industrial machinery and equipment. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How IR and XYL compare
Ingersoll Rand is the larger company, worth 1.5 times as much as Xylem ($32.0B against $22.0B).
On earnings, Xylem is cheaper: it trades at 21.2× trailing earnings, against 23.5× for Ingersoll Rand.
Ingersoll Rand grew revenue faster over the last twelve months (8.0% versus 1.9% for Xylem).
Ingersoll Rand keeps more of each dollar of sales as profit, with a net margin of 17.2% compared with 11.9% at Xylem.
Both pay dividends: Ingersoll Rand yields 0.07% and Xylem 1.8%.
Xylem scores higher on the StockData Score (23 against 17 for Ingersoll Rand), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | IR | XYL |
|---|---|---|
| Size and price | ||
| Market cap | $32.0B | $22.0B |
| Share price | $83.43 | $95.93 |
| Change, 1 year | 9.5% | −34.9% |
| Change, 5 years | 41.6% | −21.8% |
| Beta (5Y) | 0.52 | 0.16 |
| Employees | 21K | 22K |
| StockData Score | ||
| Total score | 17 | 23 (better) |
| Valuation score | 5 | 5 |
| Growth score | 1 | 4 (better) |
| Performance score | 4 | 4 |
| Health score | 4 | 6 (better) |
| Dividend score | 3 | 4 (better) |
| Valuation | ||
| P/E | 23.5× | 21.2× (better) |
| P/S | 4.0× | 2.4× (better) |
| P/B | 3.1× | 2.1× (better) |
| EV/EBITDA | 14.8× (better) | 17.6× |
| P/FCF | 21.1× (better) | 23.9× |
| PEG | – | 0.82 |
| FCF yield | 4.7% (better) | 4.2% |
| Fair value | $112.79 | $119.35 |
| Margin of safety | 26.0% (better) | 19.6% |
| Growth | ||
| Revenue growth (TTM) | 8.0% (better) | 1.9% |
| Revenue growth, 5Y average | 14.0% (better) | 13.1% |
| Net income growth (TTM) | 154% (better) | 14.1% |
| EPS growth (TTM) | 163% (better) | 16.2% |
| EPS growth, 5Y average | – | 22.9% |
| Profitability | ||
| Gross margin | 43.1% (better) | 39.8% |
| Operating margin | 22.9% (better) | 15.1% |
| Net margin | 17.2% (better) | 11.9% |
| FCF margin | 18.8% (better) | 10.2% |
| Return on equity | 13.4% (better) | 10.1% |
| Return on invested capital | 11.5% (better) | 9.0% |
| Financial health | ||
| Debt / equity | 0.45 | 0.28 (better) |
| Net debt / EBITDA | 1.42 (better) | 1.59 |
| Interest coverage | 7.2× | 36.1× (better) |
| Current ratio | 1.69 (better) | 1.39 |
| Altman Z-score | 3.58 (better) | 3.13 |
| Piotroski F-score | 5 | 7 (better) |
| Dividends and buybacks | ||
| Dividend yield | 0.07% | 1.8% (better) |
| Payout ratio | 2.2% | 37.4% |
| Years of dividend growth | – | 13 |
| Dividend growth, 5Y average | – | 9.0% |
| Buyback yield | 3.1% | 7.2% (better) |
| Shareholder yield | 3.2% | 8.9% (better) |
| Ownership | ||
| Held by institutions | 105% | 94.9% |
| Held by insiders | 0.21% | 0.20% |
| Insider net buying, 12 months | −$59.4M | $625K (better) |
| Superinvestors holding | 1 | – |
| Short interest, % of float | 3.8% | 3.8% |
Go deeper
- IR stock overview
- IR income statement
- IR valuation and score
- XYL stock overview
- XYL income statement
- XYL valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.